These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 20011979)

  • 1. Modeling of protein refolding from inclusion bodies.
    Zhang T; Xu X; Shen L; Feng Y; Yang Z; Shen Y; Wang J; Jin W; Wang X
    Acta Biochim Biophys Sin (Shanghai); 2009 Dec; 41(12):1044-52. PubMed ID: 20011979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors affecting protein refolding yields in a fed-batch and batch-refolding system.
    Mannall GJ; Titchener-Hooker NJ; Dalby PA
    Biotechnol Bioeng; 2007 Aug; 97(6):1523-34. PubMed ID: 17304557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soybean disease resistance protein RHG1-LRR domain expressed, purified and refolded from Escherichia coli inclusion bodies: preparation for a functional analysis.
    Afzal AJ; Lightfoot DA
    Protein Expr Purif; 2007 Jun; 53(2):346-55. PubMed ID: 17287130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single pH buffer refolding screen for protein from inclusion bodies.
    Coutard B; Danchin EG; Oubelaid R; Canard B; Bignon C
    Protein Expr Purif; 2012 Apr; 82(2):352-9. PubMed ID: 22343064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Techno-economic evaluation of an inclusion body solubilization and recombinant protein refolding process.
    Freydell EJ; van der Wielen LA; Eppink MH; Ottens M
    Biotechnol Prog; 2011; 27(5):1315-28. PubMed ID: 21674819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study to develop a single method for retrieving wide class of recombinant proteins from classical inclusion bodies.
    Padhiar AA; Chanda W; Joseph TP; Guo X; Liu M; Sha L; Batool S; Gao Y; Zhang W; Huang M; Zhong M
    Appl Microbiol Biotechnol; 2018 Mar; 102(5):2363-2377. PubMed ID: 29387954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solubilization and refolding of bacterial inclusion body proteins.
    Singh SM; Panda AK
    J Biosci Bioeng; 2005 Apr; 99(4):303-10. PubMed ID: 16233795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-throughput automated refolding screening of inclusion bodies.
    Vincentelli R; Canaan S; Campanacci V; Valencia C; Maurin D; Frassinetti F; Scappucini-Calvo L; Bourne Y; Cambillau C; Bignon C
    Protein Sci; 2004 Oct; 13(10):2782-92. PubMed ID: 15388864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of Solubilization and Refolding Buffers.
    Roufarshbaf M; Akbari V
    Methods Mol Biol; 2023; 2617():155-164. PubMed ID: 36656522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient solubilization of inclusion bodies.
    Freydell EJ; Ottens M; Eppink M; van Dedem G; van der Wielen L
    Biotechnol J; 2007 Jun; 2(6):678-84. PubMed ID: 17492713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Application of a prediction model in inclusion body refolding].
    Zhang T; Wang JF; Feng YY; Yang Z; Ma L; Wang XN
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Nov; 29(11):2156-60. PubMed ID: 19923054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refolding Proteins from Inclusion Bodies using Differential Scanning Fluorimetry Guided (DGR) Protein Refolding and MeltTraceur Web.
    Lee ME; Dou X; Zhu Y; Phillips KJ
    Curr Protoc Mol Biol; 2019 Jan; 125(1):e78. PubMed ID: 30371021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refolding and structural characteristic of TRAIL/Apo2L inclusion bodies from different specific growth rates of recombinant Escherichia coli.
    Kang H; Sun AY; Shen YL; Wei DZ
    Biotechnol Prog; 2007; 23(1):286-92. PubMed ID: 17269700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human growth hormone inclusion bodies present native-like secondary and tertiary structures which can be preserved by mild solubilization for refolding.
    Chura-Chambi RM; Farah CS; Morganti L
    Microb Cell Fact; 2022 Aug; 21(1):164. PubMed ID: 35978337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of ionic strength on inclusion body refolding at high concentration.
    Gabrielczyk J; Kluitmann J; Dammeyer T; Jördening HJ
    Protein Expr Purif; 2017 Feb; 130():100-106. PubMed ID: 27751932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solubility of proteins isolated from inclusion bodies is enhanced by fusion to maltose-binding protein or thioredoxin.
    Sachdev D; Chirgwin JM
    Protein Expr Purif; 1998 Feb; 12(1):122-32. PubMed ID: 9473466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solubilization and Refolding of Inclusion Body Proteins.
    Singhvi P; Panda AK
    Methods Mol Biol; 2022; 2406():371-387. PubMed ID: 35089569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemically and conformationally authentic active domain of human tissue inhibitor of metalloproteinases-2 refolded from bacterial inclusion bodies.
    Williamson RA; Natalia D; Gee CK; Murphy G; Carr MD; Freedman RB
    Eur J Biochem; 1996 Oct; 241(2):476-83. PubMed ID: 8917445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the purification of biologically active IL-7 cytokine expressed in Escherichia coli and Pichia pastoris.
    Zaremba-Czogalla M; Stumpp C; Bonifacio E; Paul R
    Protein Expr Purif; 2015 Jun; 110():65-71. PubMed ID: 25703052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single freeze-thawing cycle for highly efficient solubilization of inclusion body proteins and its refolding into bioactive form.
    Qi X; Sun Y; Xiong S
    Microb Cell Fact; 2015 Feb; 14():24. PubMed ID: 25879903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.